Enhanced Molecular Imaging and Targeted Drug Delivery Systems

The present invention relates to improved molecular imaging and targeted drug delivery systems, addressing limitations of existing multivalent molecule approaches by introducing linker molecules, modular designs, polymeric backbones, high-throughput screening methods, and optimized kits.

The original patent disclosed multivalent molecular imaging and/or targeted drug delivery methods, but these approaches were limited by non-specific binding, poor cellular uptake, and stability issues. The new inventive concept addresses these limitations by introducing novel strategies for enhancing cellular uptake, reducing non-specific binding, and increasing stability.

The inventive concept comprises a multivalent molecule conjugated with a linker molecule that enhances cellular uptake and reduces non-specific binding. The molecule features a modular design, allowing for interchangeable biomarkers and imaging labels. Additionally, the molecule can be constructed with a polymeric backbone, providing increased stability and prolonged retention in vivo. High-throughput screening methods utilizing microarray platforms with immobilized biomarkers enable efficient identification of optimal compounds. Finally, optimized kits comprising the multivalent molecule, detectable label, and spacer molecule facilitate straightforward use.

The new inventive concept introduces novel linker molecules, modular designs, and polymeric backbones that significantly improve the performance and stability of multivalent molecular imaging and targeted drug delivery systems. These innovations provide a non-obvious solution to the limitations of the original patent, offering enhanced cellular uptake, reduced non-specific binding, and increased stability.

Alternative embodiments of the inventive concept may include variations in linker molecule structures, modular design configurations, and polymeric backbone compositions. Additional variations may involve the use of different biomarkers, imaging labels, and spacer molecules to tailor the system to specific applications.

The enhanced molecular imaging and targeted drug delivery systems have significant commercial potential in the fields of cancer diagnosis and treatment, infectious disease imaging, and personalized medicine. The market for these systems is expected to grow rapidly, driven by the need for more effective and targeted therapies.